Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy

Status unconfirmed

Conditions studied: Peripheral Neuropathy

In brief

This is a nonblinded Case-only study that evaluates the effects of Agmatine Sulfate on small fiber peripheral neuropathy. Patients will be started on Agmatine sulfate (a metabolite of Arginine) and monitored for two months. Improvement will be noted on their response to the Neuropathic Pain Questionnaire. Additionally the investigators will note improvement by performing autonomic function testing at the beginning and end of the study.

Key facts

Study ID

NCT01524666

Run by

JFK Medical Center

People needed

15

Starts

2012-02-01

Expected to finish

2018-10-01

Last updated by the study team

2018-02-28

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and Women Ages 18-75 with symptoms of small Fiber Neuropathy and have been diagnosed via autonomic function testing and or skin biopsy

You may not qualify if…

• Women who are pregnant or breast feeding, patients with history of substance abuse, and patients with myelopathy

Where it is running

• JFK Medical Center — Edison, New Jersey, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.